Question 1

Am I eligible for this trial based on my health history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma clinical trial (NCT04212013). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of ibrutinib and rituximab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma clinical trial (NCT04212013). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma clinical trial (NCT04212013). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma clinical trial (NCT04212013). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma clinical trial (NCT04212013). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma clinical trial (NCT04212013). Contact the study team or your healthcare provider for specific answers.

What this study is about